Keryx Biopharma (KERX) Prices 7.02M Common Offering at $4.70/Share
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Join SI Premium – FREE
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) has priced a 7,021,277 share common offering at $4.70 per share.
The price is a 4.5 percent decrease from the closing price of $4.92 yesterday.
The aggregate gross proceeds, before commissions and expenses, of the offering will be approximately $33 million.
The price is a 4.5 percent decrease from the closing price of $4.92 yesterday.
The aggregate gross proceeds, before commissions and expenses, of the offering will be approximately $33 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
- Splash Beverage Group Inc. (SBEV) files for 5M share offering by selling stockholders
- Roots Corporation to go private in C$4.10-per-share deal with Marquee Brands
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
